“…The procedure-related complication rate in the present study was higher than the reported rates in previous studies performed mainly for stenotic lesions and in the chronic stroke stage. [2][3][4][5][6][7][8][9][10] This may be because TAS for occluded lesions tends to induce distal embolism, intracranial hemorrhage involving hemorrhagic transformation and cerebral hyperperfusion syndrome, and vessel injury or rupture in comparison with the treatment of stenotic lesions. Because distal embolism tends to occur for a lesion crossed by a microguidewire, balloon catheter, or stent and is especially common with occluded lesions, the use of an embolic protection device with proximal flow control may reduce the incidence of this complication.…”